Kidney Disease
Children with CKD experience increased burden of fatigue independent of disease severity
Regardless of chronic kidney disease stage, children experience high and consistent burden of impairment across many patient-reported measures, according to data published in the American Journal of Kidney Disease.
Americans with CKD more likely to have CVD, die before ESKD than Japanese counterparts
Compared with Japanese patients with chronic kidney disease, Americans with CKD are more likely to experience CVD events or death before developing end-stage kidney disease, according to a published study.
Conservative kidney management decision aid increases discussion of treatment
Offering a decision aid regarding conservative kidney management to patients with advanced kidney disease and their family led to increased discussion of the treatment option with providers, according to a study.
Caregivers of patients with autosomal dominant polycystic kidney disease report burdens
More than half of caregivers of patients with autosomal dominant polycystic kidney disease report significant emotional impacts on their daily life, according to published data.
In nephrology, the conundrum regarding vascular access choice continues
“Vascular access is the Achilles’ heel of dialysis therapy.”
AKF gains sponsorship for its kidney disease educational campaigns
The American Kidney Fund announced it gained sponsorship for its education and awareness campaigns for complement 3 glomerulopathy and IgA nephropathy from Novartis Pharmaceuticals Corporation, according to a press release.
Intrarenal podocalyxin level may predict dialysis-free survival in diabetic kidney disease
Among patients with diabetic kidney disease, intrarenal podocalyxin level was an independent predictor of dialysis-free survival, according to data published in Kidney Medicine.
CMS approves additional entities for second year of Kidney Care Choices model
CMS has approved 50 new kidney contracting entities to participate in the second year of the Kidney Care Choices demonstration, which focuses on providing care for patients with advanced chronic kidney disease, according to a press release.
FDA accepts supplemental new drug application for Jardiance for CKD
The FDA accepted a supplemental new drug application for Jardiance, empagliflozin tablets, which may reduce kidney disease progression and cardiovascular death in adults with chronic kidney disease, according to the press release.
Intensive BP control may delay kidney replacement therapy in patients with advanced CKD
Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset of kidney replacement therapy, according to data published in the Journal of the American Society of Nephrology.